MedPath

国药集团汕头金石制药有限公司

Ownership
-
Established
1987-09-10
Employees
-
Market Cap
-
Website
www.jinshipharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

158

NMPA:158

Drug Approvals

Ambroxol Hydrochloride Tablets

Product Name
盐酸氨溴索片
Approval Number
国药准字H20083547
Approval Date
Jun 19, 2023
NMPA

Calcium Gluconate Tablets

Product Name
葡萄糖酸钙片
Approval Number
国药准字H20123121
Approval Date
Sep 6, 2021
NMPA

Paracetamol

Product Name
对乙酰氨基酚
Approval Number
国药准字H44021507
Approval Date
Jul 9, 2021
NMPA

Piperazine Phosphate

Product Name
磷酸哌嗪
Approval Number
国药准字H44021509
Approval Date
Jul 8, 2021
NMPA

Oyster Shell Calcium

Product Name
牡蛎碳酸钙
Approval Number
国药准字H44024508
Approval Date
Jul 8, 2021
NMPA

Piperazine Citrate

Product Name
枸橼酸哌嗪
Approval Number
国药准字H44021516
Approval Date
Jul 8, 2021
NMPA

Calcium Gluconate Buccal Tablets

Product Name
葡萄糖酸钙含片
Approval Number
国药准字H20053898
Approval Date
Jul 8, 2021
NMPA

Nifedipine

Product Name
硝苯地平
Approval Number
国药准字H44021513
Approval Date
Jul 8, 2021
NMPA

Calcium Gluconate Buccal Tablets

Product Name
葡萄糖酸钙含片
Approval Number
国药准字H20053897
Approval Date
Jul 8, 2021
NMPA

Bromhexine Hydrochloride Tablets

Product Name
盐酸溴己新片
Approval Number
国药准字H44021078
Approval Date
Apr 7, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.